Ticker brief
ABT ABBOTT LABORATORIES .
Consumer, Non-cyclical · Healthcare-Products
last close
$103.70
1 day
+1.2%
14 days
+4.1%
mkt cap
$166.2B
signals 14d
24
authors 14d
19
crowd 14d
+0.7σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 25% mid · 52 pctile own 1y | IV/HV 0.85× |
| Skew — 25Δ RR 30d | -0.020 73 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +0.17 elevated | 5-session Δ +0.04 (as of 2026-07-06) |
| OI alarm | quiet | last alarm 2026-05-12 (z=2.0) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-16 · now -0.40 (−1 bearish … +1 bullish)
Who spoke19
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @SunriseTrader | B | -0.64 | 4 | +0.31 |
| @TENETTRADEGROUP | C | -0.65 | 2 | +0.40 |
| @42traders | B | -1.22 | 2 | +0.10 |
| @StockWorthyApp | C | -0.77 | 1 | +0.00 |
| @CHItrader | B | -0.22 | 1 | +0.50 |
| @alexkoh | B | -1.37 | 1 | +0.50 |
| @OpenOutcrier | C | · | 1 | +0.20 |
| @_TP888 | C | +0.93 | 1 | +0.40 |
| @FL0WG0D | C | · | 1 | +0.40 |
| @TheNewMoney_app | C | · | 1 | +0.35 |
| @kiantrades | C | -1.01 | 1 | +0.45 |
| @Sam_Badawi | C | -3.18 | 1 | +0.30 |
| @USAnt_IDEA | C | -0.64 | 1 | +0.20 |
| @unusual_whales | C | · | 1 | +0.30 |
| @EJLandis | C | +0.61 | 1 | +0.50 |
| @davevermilion | A | -0.54 | 1 | +0.40 |
| @Cessnadriver50 | B | -0.61 | 1 | +0.60 |
| @OptionSamurai | C | · | 1 | +0.50 |
| @MarioNawfal | C | -3.00 | 1 | -0.40 |
Recent signals24of 24 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @MarioNawfal | -0.40 | Abbott reportedly recalls 13 million pregnancy tests over false-positive results | -1.1% | tweet ↗ |
| 2026-10-15 | @42traders | +0.00 | Portfolio update reports closed and fresh options positions, premium, margin and realized profit. | -0.9% | tweet ↗ |
| 2026-10-15 | @OptionSamurai | +0.50 | Scan estimates an ABT call could gain 220% if shares reach the cited analyst target. | -0.9% | tweet ↗ |
| 2026-10-15 | @Cessnadriver50 | +0.60 | Highlights strength in defensive stocks and rejects Treasuries as an investment alternative. | -0.9% | tweet ↗ |
| 2026-10-12 | @davevermilion | +0.40 | Says a basket of defensive consumer and healthcare stocks looks good; KR omitted due to ticker cap. | +1.8% | tweet ↗ |
| 2026-10-11 | @EJLandis | +0.50 | Identifies three dividend-growth portfolio standouts using yield, growth and valuation metrics. | +4.1% | tweet ↗ |
| 2026-10-08 | @unusual_whales | +0.30 | Discloses Trump's August trades, led by a Meta purchase and five other buys of up to $5 million each. | +5.3% | tweet ↗ |
| 2026-10-08 | @USAnt_IDEA | +0.20 | Trump's financial disclosure reportedly shows August purchases across Meta and several other public equities. | +5.3% | tweet ↗ |
| 2026-10-08 | @Sam_Badawi | +0.30 | Reports President Trump's disclosed August securities purchases; output is capped at six directly bought assets. | +5.3% | tweet ↗ |
| 2026-10-07 | @kiantrades | +0.45 | Lists notable bullish call flow and bearish put flow with strikes, expiries and premiums. | +5.0% | tweet ↗ |
| 2026-10-07 | @TheNewMoney_app | +0.35 | Reports a $354,167 purchase of ABT 130 calls expiring September 17, 2027. | +5.0% | tweet ↗ |
| 2026-10-07 | @FL0WG0D | +0.40 | Flags $354K of call buying in ABT. | +5.0% | tweet ↗ |
| 2026-10-07 | @_TP888 | +0.40 | Reports $99K of ABT call buying at the 99 strike with shares at 97.82. | +5.0% | tweet ↗ |
| 2026-10-07 | @SunriseTrader | +0.10 | Reports full exits from ABT and XBI at a profit. | +5.0% | tweet ↗ |
| 2026-10-07 | @OpenOutcrier | +0.20 | Lists positive analyst coverage initiations for multiple stocks. | +5.0% | tweet ↗ |
| 2026-10-05 | @TENETTRADEGROUP | +0.40 | Rothschild Redburn upgraded ABT to Buy and raised its target to $127 from $119. | +3.6% | tweet ↗ |
| 2026-10-05 | @alexkoh | +0.50 | Reports FDA approval of new CardioMEMS HF System capabilities. | +3.6% | tweet ↗ |
| 2026-10-05 | @42traders | +0.20 | Discloses six fresh premium-selling positions and summarizes realized and open portfolio results. | +3.6% | tweet ↗ |
| 2026-10-05 | @SunriseTrader | +0.50 | Reports selling profit-taking shares and retaining the full swing. | +3.6% | tweet ↗ |
| 2026-10-05 | @SunriseTrader | +0.25 | Plans to take partial profits in ABT soon. — States a forward intention to take profits near the $100 area. | +3.6% | tweet ↗ |
| 2026-10-05 | @SunriseTrader | +0.40 | Says an oversold bounce and backtest of the earnings gap have confirmed. | +3.6% | tweet ↗ |
| 2026-10-05 | @CHItrader | +0.50 | FDA approved updates enabling new patient capabilities for Abbott's CardioMEMS system. | +3.6% | tweet ↗ |
| 2026-10-03 | @StockWorthyApp | +0.00 | Lists SCHD's largest holdings and their portfolio weights. | +6.4% | tweet ↗ |
| 2026-10-02 | @TENETTRADEGROUP | +0.40 | Rothschild Redburn upgraded Abbott to Buy from Neutral and raised its price target to $127 from $119. | +6.4% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.